Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFB): a clinical study protocol
Colin E. Swenson, William R. Hunt, Candela Manfredi, Diana J. Beltran, Jeong S. Hong, Brian R. Davis, Shingo Suzuki, Cristina Barillá, Andras Rab, Cynthia Chico, Joy Dangerfield, Ashleigh Streby, Elizabeth M. Cox, Arlene Stecenko, Adrianna Westbrook, Rebecca Kapolka, Eric J. Sorscher
medRxiv 2024.07.19.24310604; doi: https://doi.org/10.1101/2024.07.19.24310604